| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3736654583e60531b7fac435ad82c5f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7a57c6b27249359fff1fa4dca8a5c0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2bcaf91101a370a3d64e3190366357f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate |
2018-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6b918649528043ff074feb7f5b4491a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f140c8dc29984308a6c04fdc58cb78b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04751b9f01690a59e19192f6e66bc91a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bbad1d60151d99ff739930bae69ef42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a38da94520b5349573e2ace2a0917358 |
| publicationDate |
2018-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018228978-A1 |
| titleOfInvention |
Mirna-574-5p as a biomarker for stratification of prostaglandin e-dependent tumors |
| abstract |
The present invention relates to the field of diagnostic methods. More specifically, it relates to a method for identifying a subject suffering from a prostaglandin E-dependent tumor as being susceptible to a therapy with an inhibitor of prostaglandin E formation comprising the steps of determining in a test sample of the subject the amount of microRNA-574-5p, comparing the determined amount to a reference, and identifying a subject suffering from a prostaglandin E- dependent tumor as being susceptible to a therapy with an inhibitor of prostaglandin E formation based on said comparison. Moreover, the invention also encompasses the use of microRNA-574-5p or a detection agent that specifically binds thereto in a sample of a subject suffering from a prostaglandin E-dependent tumor for identifying the subject as being susceptible to a therapy with an inhibitor of prostaglandin E formation and a device as well as a kit for carrying out the method of the invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023152568-A3 |
| priorityDate |
2017-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |